The translocation t(11;14)(q13;q32) occurs in about 15% of patients with splenic lymphoma with villous lymphocytes (SLVL) or the closely related disorder lymphoplasmacytic lymphoma (LPL). To characterize the nature and frequency of rearrangements of the BCL-1 locus in SLVL/LPL and t o document the effect of these genetic alterations on the expression of the cyclin D l gene, we analyzed 22 cases of SLVL/LPL with defined cytogenetic abnormalities by both conventional electrophoresis (CE) and pulse-field gel electrophoresis (PFGE) and by Northern blotting. Four SLVL/LPL cases showed rearrangement of the BCL-1 locus. In two cases with t(l1; 14)(q13;q32), different breakpoints were identified; one mapped adjacent t o the major translocation cluster (MTC) and the other within a 28-kb region telomeric the two SLVL/LPL cases with t(l1; 14)(q13;q32). In cases that lacked a cytogenetically demonstrable t(l1; 14) translocation, no cyclin D l transcript was detected. Analysis of the BCL-1 locus was also performed in three other cases of Bcell disorders with t(l1; 14)(q13;q32) detected cytogenetically. Two cases were analyzed by Southern blot and showed rearrangement of the BCL-1 locus. Expression of high-level normal-sized and/or truncated cyclin D l transcript was also detected in these cases. These data show the importance of PFGE in the detection of rearrangements in the BCL-1 locus and show further the complexity of rearrangements in this locus.
The translocation t(11;14)(q13;q32) occurs in about 15% of patients with splenic lymphoma with villous lymphocytes (SLVL) or the closely related disorder lymphoplasmacytic lymphoma (LPL). To characterize the nature and frequency of rearrangements of the BCL-1 locus in SLVL/LPL and t o document the effect of these genetic alterations on the expression of the cyclin D l gene, we analyzed 22 cases of SLVL/LPL with defined cytogenetic abnormalities by both conventional electrophoresis (CE) and pulse-field gel electrophoresis (PFGE) and by Northern blotting. Four SLVL/LPL cases showed rearrangement of the BCL-1 locus. In two cases with t(l1; 14)(q13;q32), different breakpoints were identified; one mapped adjacent t o the major translocation cluster (MTC) and the other within a 28-kb region telomeric of it. In a third case of SLVL with no cytogenetic abnormality of llq13, a novel breakpoint approximately 100 kb centromeric of MTC was detected by PFGE. The fourth case, which had a normal karyotype, demonstrated rearrangement with a BCL-1 probe immediately telomeric of MTC. This case may HE TRANSLOCATION t(l1; 14)(q13;q32) is found in a variety of B-lymphoid malignan~ies."~ This chromosome translocation joins the Ig heavy chain gene locus (IgH) on 14q32 to the BCL-1 locus on chromosome 11q13.6-9 Rearrangements of the BCL-1 locus covering a region of 63 kb have been reported in several subtypes of B-cell nonHodgkin's lymphoma (B-NHL),6,*,'' but are frequently found in diffuse centrocytic or intermediate B-NHL.'"I5 These two closely related histologic subtypes of B-NHL are grouped under the term of mantle-cell (MC) lymphoma!,16 Recently, a gene located 110 kb telomeric of the BCL-l major translocation breakpoint cluster region (MTC) has been cl~ned.'~~'' The gene is a member of the cyclin gene family and is now formerly designated CCNDl or cyclin
The gene encodes a small 295 amino acid protein17 and is expressed in a wide range of human tissues,17 but is not normally expressed in any cell line of lymphoid or myeloid lineages?' Cyclin D l is also overexpressed in breast and squamous cell carcinoma cell lines that show amplification of the llq13 region.23
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact. the two SLVL/LPL cases with t(l1; 14)(q13;q32). In cases that lacked a cytogenetically demonstrable t(l1; 14) translocation, no cyclin D l transcript was detected. Analysis of the BCL-1 locus was also performed in three other cases of Bcell disorders with t(l1; 14)(q13;q32) detected cytogenetically. Two cases were analyzed by Southern blot and showed rearrangement of the BCL-1 locus. Expression of high-level normal-sized and/or truncated cyclin D l transcript was also detected in these cases. These data show the importance of PFGE in the detection of rearrangements in the BCL-1 locus and show further the complexity of rearrangements in this locus. Splenic lymphoma with villous lymphocytes (SLVL) is a distinct B-lymphoproliferative disorder characterized by splenomegaly and circulating lymphocytes with short and thin cytoplasmic villiz4 A monoclonal serum Ig band and lymphoplasmacytic features are often present and SLVL may be considered within the spectrum of lymphoplasmacytic lymphoma (LPL). The marker profile of SLVL includes moderate to strong expression of surface Ig, CD22, FMC7, and CD24, whereas it lacks expression of CD5 and the hairy cell leukemia markers, HC2 and B-l~-7.'~ The disease usually has a benign clinical course but occasionally undergoes transformation to large-cell lymphoma. We have shown by cytogenetic analysis that approximately 15% of SLVL cases carry the t(l1; 14)(q13;q32) transl~cation.~ To determine both the frequency and nature of rearrangements of the BCL-1 locus and their possible effects on expression of the cyclin Dl gene in SLVLILPL, we analyzed 22 cases of SLVLI LPL, including 3 cases with t(11;14)(q13;q32), using both conventional electrophoresis (CE) and pulse-field gel electrophoresis (PFGE) and probes from the BCL-1 and cyclin Dl loci. Northern blot analysis was used in these cases to determine the level of expression of the cyclin Dl gene and in particular to investigate any association of SLVLnPL phenotype with cyclin D l overexpression. Our analysis also included 5 cases of other B-cell disorders, 3 of which have chromosome l lq13 abnormalities.
MATERIALS AND METHODS
Patients. Peripheral blood and/or spleen from 27 patients with a B-lymphoproliferative disorder were investigated. These cases included 16 cases with SLVL, 6 with LPL, 4 with MC-NHL, and 1 case of chronic lymphocytic leukemia with more than 10% prolymphocytes (CLLRL). All cases analyzed had peripheral blood involvement on the basis of light microscopy morphology and immunologic markers that demonstrated a clonal B-cell population with light chain restriction. In all the cases, diagnosis was based on peripheral blood morphology, bone marrow, and, in many cases, spleen histology. Diagnosis was made according to the French-American-British (FAB) proposals.25 Details of the histologic material reviewed, the immunophenotypic markers, and cytogenetics of some of the cases analyzed are shown in Table 1 .
Sumpfes. Peripheral blood mononuclear cells were isolated by Lymphoprep gradient centrifugation and used for immunophenotyping, cytogenetics, and molecular analysis.
PFGE. High molecular weight DNA was prepared from mononuclear cells resuspended in 1% low melting temperature agarose at 3 X lo7 celYmL. The agarose blocks were then incubated at 50°C for 48 hours in a solution of 0.5 m o m EDTA, pH 9.5, containing 1 % sodium lauryl sarcosine and 1 m@mL proteinase K. The solution was changed every 24 hours. Blocks were stored at 4°C in a fresh solution of 0.5 m o m EDTA containing 1% sarcosine without proteinase K. Before digestion, blocks were washed overnight at 4°C in 10 mmol/L Tris-HC1, pH 8, 1 mmom EDTA (TE) containing 0.1 mmom phenylmethylsulfonyl fluoride (PMSF). Blocks were washed for an additional 3 hours in TE without PMSF and one-third of a block containing lo6 cells was digested in situ with 30 to 40 U of enzyme for 6 hours or overnight. The blocks were then placed in 1% agarose gel and subjected to electrophoresis in a clamped homogenous electric field (CHEF) at 18°C for 24 hours at 200 V with two different pulse time (60 seconds for 15 hours and 90 seconds for 9 hours). Concatemers of X (New England Biolabs, Beverly, MA) and Saccharomyces cerevisiue were used as size stan- Hybridization was performed at 65°C in a buffer containing 10% dextran sulfate, 0.5 m o m sodium phosphate, pH 7.5, 1% sodium dodecyl sulfate (SDS), and l00 pg/mL salmon sperm DNA. After hybridization, filters were washed once with 2 x SSC at 65°C for 10 minutes, followed by two washes with 2 x SSCl 1 % SDS for 20 minutes. Additional washes with 0.1 X SSC/O. 1 % SDS for 15 minutes were performed when necessary.
DNA probes.
The MTC or BCL-l probe "b" is a 2.1-kb Sst I fragment.' Probes q13-1 and q13-7 are 1.0-kb EcoRySsf I and 2-kb BumHUsst I fragments, respectively.' p94PS is a 450-bp Pvu 11-Smu I fragment that lies approximately 23 kb telomeric of MTC.l2 The location of these probes within the BCL-l locus is shown in Fig 1. pPL-8 is a 1.4-kb EcdU cDNA probe from the cyclin Dl gene and is a subclone of the L~l -4 . '~ Each probe was analyzed with the restriction enzymes BamHI, EcoRI, HindIJI, and Sst I. The probe for IgH joining region 3'JH(C76R51A) is a 2.5-kb EcoRI-Bgl II. 26 Cp is a 1.2-kb EcoRI fragment from the Ig heavy chain constant region.27 GAPDH is a cDNA probe of the rat glyceraldehyde-3-phosphate dehydrogenase gene?' RNA extraction and analysis. Total RNA was isolated by the guanidinuim isothiocynate methodz9 or by the guanidinuim isothiocyanatekesium chloride method." RNA was electrophoresed through denaturing formaldehyde agarose gels and transferred to nylon filters." RNA was immobilized by irradiation with UV light and hybridized to [32P]-labeled DNA probes in 0.5 m o m sodium phosphate/7% SDS buffer." Hybridization with the GAPDH probe was used to document the quality and equal loading of RNA in each lane.
RESULTS
All 27 cases studied exhibited clonal rearrangement of JH and Cp. All samples were analyzed for rearrangement of the BCL-2 gene within the major and minor breakpoint cluster region and no rearrangements were identified (data not shown).
Rearrangement of BCL-1 and cyclin D1 in SLVLfLPL without t(ll;14)(q13;q32) translocation. A total of 19 cases of SLVWLPL without t( 11; 14) were analyzed for rearrangement of the BCL-1 locus and the cyclin Dl gene using 4 BCL-1 probes and a cDNA clone from the cyclin Dl gene.
Using CE, BCL-1 rearrangement was detected in only 1 case (case no. 4, Table 2 ) with the q13-1 probe in Sst I and EcoRI restriction digests (Fig 2) . Eight of the 19 SLVULPL cases were analyzed further by PFGE, using the MTC probe and Nor I and Eag I digests, to expand the DNA region of germline and an EcoRI band 0.5 kb smaller than the germthe BCL-l locus analyzed. Rearrangement with the MTC line. Taken together with the observation that rearrangement probe was not detected in any case, including the 1 that was not detected by PFGE, it is possible that the reshowed BCL-l rearrangement by CE. Southern analysis of arrangement may be caused by a small deletion of 0.5 kb this particular case showed an Sst I band larger than the that eliminated an Sst I site (Fig IA) . PFGE analysis of case no. 3 showed a rearranged fragment of 200 kb detected with the MTC probe in the Not I digests (Fig 3A) . The same-sized rearrangement fragment was also obtained with the q13-7 probe (Fig 3B) , but no rearrangement was observed with the Sac 11, Eag I, or Nae I digests (data not shown). These results suggest that the breakpoint in this case is at a maximal distance of 200 kb from the MTC and q13-7 probes. Given the clustering of the rare restriction sites in the HTF island approximately 100 kb away from MTC (Fig IB) , it was concluded that the 3667 breakpoint in this case is 100 kb centromeric to MTC ( Fig  1B) .
All the SLVLLPL cases were analyzed for rearrangement within the cyclin Dl gene, but no rearrangement was detected in any of the samples analyzed by CE or PFGE. ;14)(q13;q32) translocation. Two SLVL and 1 LPL had t(11; 14)(q13;q32) identified cytogenetically (cases no. 1, 2, and 17; Table 1 ). Material for PFGE analysis was available from cases no. l and 17. In both cases, a germline band and an additional rearranged band were detected with the MTC probe in Not I digests (Fig 3A) . These 2 cases were also analyzed by PFGE with the probe q13-7, which detected rearranged fragments of approximately 100 kb in both of them (Fig 3B) , suggesting that the breakpoint is located within a 28-kb region that separates the MTC and the q13-7 probes. Moreover, the rearranged fragments of different sizes detected by the MTC and the q13-7 probes may indicate that each of these probes detected a different derivative chromosome. The breakpoints in case no. 1 were also detected by CE with the MTC probe in BamHI, HindIII, and EcoRI digests, and these results mapped the breakpoints immediately telomeric of MTC. However, no rearrangements in case no. 17 were detected by CE. The reasons for this are unclear; lack of suitable material has precluded further analysis. No rearrangement was detected by CE with the MTC and p94PS probes in case no. 2. All samples were further analyzed with the cyclin Dl cDNA probe and no rearrangement was observed in any of the samples analyzed by CE or PFGE.
Rearrangement of BCL-I and cyclin D l in SLVLJLPL with t(ll

Rearrangement of the BCL-I locus and the cyclin D l gene in other B-lymphoproliferative disorders.
Material for PFGE analysis was available from 4 cases of MC-NHL (cases no. 23 through 26). t(l1; 14)(q13;q32) was detected cytogenetically in cases no. 23 and 24. BCL-l rearrangements were detected in these 2 cases in Not I and Eag I digests and in the MTC probe (Fig 3A and C) . The precise localization of breakpoints in these cases was also determined by CE and is shown in Fig 1A. No rearrangements were detected in cases no. 25 and 26 even by PFGE analysis.
Involvement of the IgH locus. In the cases with t(l1; 14)(q13;q32) that have been cloned and sequenced, the breakpoints in the IgH locus are located in the joining regions, ie, J4,',* J5,9 or outside the JH within or near the switch region.3' Therefore, the cases with BCL-1 rearrangement were analyzed for IgH involvement by reprobing the Not I and Eag I PFGE filters with the JH probe. In each sample, one or more hybridizing bands were detected. None of the rearranged Not I fragments observed with the MTC probe comigrated with any of the fragments hybridizing to the JH probe. The same hybridizing pattern as for JH was obtained with the C p probe (data not shown), suggesting no breakpoint between the JH and the C p probes in the samples analyzed. However, in case no. 24, a clear comigration of the Eag I rearranged band obtained with MTC and JH probes was detected (Fig 3C) . Comigration between rearranged bands obtained with MTC and JH probe was also detected by CE in this patient and in case no. 1. Table 2 and Fig 4. Expression of a normal-sized cyclin Dl transcript of 4.4 and 1.7 kb'X.34 was detected in 1 SLVL and 1 LPL (cases no. 2 and 17) with t(11;14)(q13;q32). However, the cyclin D1 gene was not expressed in any of the SLVLLPL cases without the t(l1; 14)(q12;q32) and/or BCL-I rearrangement. The major 4.4-kb mRNA transcript was absent in case no. 27; instead, an abundant but truncated form of the cyclin D1 transcript of approximately 2.6 kb was detected (Fig 4) . Cyclin Dl expression was seen in 3 of 4 cases of MC-NHL, including case no. 26, which showed no BCL-l rearrangement by CE or PFGE analyses.
DISCUSSION
We have investigated the molecular genetics in 27 cases of B-lymphoid malignancy with particular emphasis on SLVL to see whether ( I ) DNA analysis may disclose cases with 1 lq13 involvement not demonstrable by cytogenetics, (2) the breakpoints within the BCL-l are distinct in SLVL/ LPL from those in MC-NHL, and (3) these alterations affect the expression of the cyclin Dl gene. We have used PFGE to expand the DNA region of the BCL-I locus analyzed, thus increasing the possibility of detecting rearrangements. In this respect, the breakpoints in cases no. 3 and 17 could only be detected by PFGE. The long-range restriction map of the BCL-1 locus and the presence of an HTF island S' of the cyclin D1 gene coding region show that a DNA region of 350 kb centromeric of the cyclin D1 gene can be easily analyzed using one or more of the rare cutting restriction enzymes mapped in this region and any of the BCL-1 probes.
The use of PFGE technique to detect breakpoints scattered at a large distance from the cyclin Dl gene becomes even more important because breakpoints located 200 kb centromeric (this study) and SO0 kb on either side of the gene have been reported.3s In this respect, PFGE of BssHII or Mlu I digests and hybridization of filters with one probe such as MTC would analyze a region of 600 kb centromeric of the cyclin Dl gene'6 (Jadayel et al, unpublished results).
The rearranged bands detected by PFGE analysis are not caused by technical artifact because DNA from 4 different controls were studied without similar findings. Moreover, the rearranged bands cannot be caused by polymorphism because there is variation in the relative intensity of the normal and rearranged bands that reflects the proportion in the blood sample of leukemic cells with the rearrangement. Furthermore, different-sized rearranged fragments were obtained with different BCL-l probes, indicating that the altered restriction fragments are caused by true rearrangements.
The results presented here indicate that the breakpoints in SLVLLPL are scattered, as in the case of Mc-NHL; they involve the MTC; or are located within a 28-kb region telomeric of it. We have also demonstrated a new breakpoint 1 0 0 kb centromeric of MTC that was not detectable by CE (Fig 5) . Of the 4 cases of SLVULPL and Mc-NHL with t(l1;14)(q13;q32) translocation and a breakpoint in the BCL-1 locus, 2 showed comigration with the JH probe. The lack of comigration would suggest that the activation of the a centromere ql3-1 ql3-7 MTC p94PS 3669 cyclin D1 gene does not always result from its juxtaposition to Ig sequences but may result from the elimination. by the translocation, of a distant negative control element located near or beyond the MTC.I4."' This study has widened the spectrum of B-cell malignancies in which the BCL-I locus is rearranged to include SLVL and LPL. RNA analysis of the expression of cyclin D1 gene in these subtypes of B-NHL showed that, in samples with t( 1 I ; 14)(q13;q32), as for Mc-NHL Iymph~ma,"'~~' deregulation leading to overexpression of the cyclin D1 gene mRNA seems to be a functional consequence of such rearrangements. However, the effect of the translocation on the expression of the cyclin D1 appears to differ in different cell types. High levels of normal-sized cyclin Dl transcripts were observed in Mc-NHL, whereas high levels of truncated transcripts were found in a case of CLLPL (this study), in 2 prolymphocytic variant cell lines with t( 1 I ; 14)(q13;q32),20 and in a lymphoma cell line.% In contrast, the 2 SLVLLPL cases analyzed had low to moderate levels of cyclin Dl; in these cases, the transcripts were apparently of normal size. Expression of the cyclin D 1 gene in SLVULPL may indicate an aggressive clinical course, because case no. 2 developed generalized lymphadenopathy but with no histologic evidence of transformation, whereas case no. l 7 transformed to large-cell lymphoma with a very aggressive disease course. However, case no. 1 is clinically stable and has not required therapy. As preliminary data, these observations may suggest that detectable levels of cyclin Dl in SLVLLPL may be associated with a more aggressive clinical course.
Our analysis of cases of SLVLLPL and Mc-NHL showed two further points. Firstly, the absence of cyclin Dl expression in case no. 3 suggests that breakpoints centromeric of MTC do not deregulate the cyclin Dl gene. Secondly, the detection of a shortened form of cyclin D1 transcript in case no. 26, with no BCL-I rearrangement even using PFGE, may suggest that activation of the cyclin Dl gene is not always associated with a breakpoint in the BCL-I locus but may result from the loss, because of the use of different polyadenylation signals, of the 3' regulatory sequences implicated in mRNA Alternatively, deregulation of cyclin D1 expression could be caused by mutations of regulatory elements of the gene. For personal use only. on October 26, 2017. by guest www.bloodjournal.org From cal course is a further proof of the involvement of cyclin D1 in B-cell lymphomagenesis.
